XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
  AIDS
  Influenza
  MRSA
  Tuberculosis
  Shigella
  HCV
  SARS
  Ebola
  Dengue
  Malaria
  Pertussis
  Mumps
  Prion Diseases
  Small Pox
  Anthrax
  Leishmaniasis
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
 
 India
Search

Last Updated: Nov 18, 2006 - 12:32:53 PM

Influenza Channel
subscribe to Influenza newsletter

Latest Research : Infectious Diseases : Influenza

   DISCUSS   |   EMAIL   |   PRINT
CDC Declared Spanish Flu Virus a Select Agent
Oct 23, 2005 - 6:14:00 PM, Reviewed by: Dr.

�We�ve learned why this virus was so deadly and we know it�s easily transmitted from person to person. But there is a lot we don�t know so it�s only logical that we take immediate steps to regulate this virus as a select agent as an added way to protect the public.�

 
The Centers for Disease Control and Prevention (CDC) published on 20 October, 2005 in the Federal Register an interim rule declaring the strain of influenza responsible for the 1918 pandemic as a select agent. There are currently 41 other agents and toxins listed as select agents under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002.

This action follows recent work done by CDC scientists to successfully reconstruct the 1918 virus in hopes of better understanding it. The virus was reconstructed to aid public health officials in preparing for the possibility of another pandemic of influenza. It will also be helpful to biomedical scientists as they seek to understand what made the virus so harmful and to develop better antiviral drugs and influenza vaccines.

�We�ve learned why this virus was so deadly and we know it�s easily transmitted from person to person,� said CDC Director Dr. Julie Gerberding. �But there is a lot we don�t know so it�s only logical that we take immediate steps to regulate this virus as a select agent as an added way to protect the public.�

Under provisions outlined in the interim rule, all entities (e.g., scientists and researchers) that possess, use or transfer the 1918 strain of influenza or the eight key gene regions of the 1918 virus are required to register with the CDC. People, labs, and other facilities that work with select agents are required to ensure that they can safely handle the virus as outlined in the CDC/NIH Biosafety in Microbiological and Biomedical Laboratories, 4th edition. In addition, they are required to increase safeguards and security measures for the virus, including controlling access, screening personnel, and maintaining records to be included in a national database with records from others registered. The Act imposes criminal and civil penalties for inappropriate use of select agents and toxins.

In light of this groundbreaking scientific research done to recreate the 1918 pandemic influenza virus, CDC asked a workgroup of scientists from the National Institutes for Health (NIH), the Food and Drug Administration (FDA), the Department of Defense, and the Department of Agriculture to determine if the newly created virus should be added to the select agent list. The group used four criteria to determine whether to include the 1918 strain on the select agent list � 1) the effect on human health of exposure to the agent or toxin; 2) the degree of contagiousness of the agent or toxin and the methods by which the agent or toxin is transferred to humans; 3) the availability and effectiveness of pharmacotherapies and immunizations to treat and prevent any illness resulting from infection by the agent or toxin; and 4) the needs of children and other vulnerable populations. Using these criteria, the workgroup unanimously agreed that the virus warranted select agent status.
 

- Centers for Disease Control and Prevention (CDC), U.S.
 

www.cdc.gov

 
Subscribe to Influenza Newsletter
E-mail Address:

 



Related Influenza News

Are influenza vaccines worth the effort?
Oseltamivir significantly reduces the risk of death from influenza
Prisons Unprepared for Flu Pandemic
University of Pittsburgh receives $1.3 million grant for developing a promising avian flu vaccine
Novel DNA-Based H5N1(Avian) influenza vaccine
Genetic differences between potential pandemic influenza strains outlined
Avian flu virus needs only minor adaptations to infect humans
Influenza-Associated Hospitalization in a Subtropical City
SRL Ranbaxy offers a quicker bird flu diagnostic test
Bird flu vaccine may be fruitless


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us